Cannabis News
$9,500,000 Fine for Illegal NY Dispensary That Didn’t Listen to State’s Warnings to Shut Down Operations
Published
3 months agoon
By
admin
In a significant move aimed at regulating the burgeoning cannabis industry in New York, Attorney General Letitia James has announced a substantial penalty against George West, the owner of the unlicensed cannabis shop Jaydega 7.0 located in Canandaigua. The judgment, which totals $9.5 million, underscores the state’s commitment to enforcing its cannabis laws and ensuring that operators comply with legal standards. This article delves into the details of the case, its implications for the cannabis industry in New York, and the broader context of cannabis regulation in the United States.
Background on Cannabis Legalization in New York
New York’s journey toward cannabis legalization began in earnest with the passage of the Marijuana Regulation and Taxation Act (MRTA) in March 2021. This landmark legislation allowed adults aged 21 and over to possess and use cannabis for recreational purposes. The MRTA also established a regulatory framework for the cultivation, distribution, and sale of cannabis products, aiming to create a safe and equitable market.
Regulatory Framework
The Office of Cannabis Management (OCM) was created to oversee the implementation of the MRTA, ensuring that licensed operators adhere to strict guidelines regarding product safety, marketing, and distribution. One of the primary goals of this regulatory body is to eliminate illegal cannabis operations that undermine public safety and tax revenue.
The Case Against George West
Jaydega 7.0 opened its doors in September 2022, quickly attracting attention for its unlicensed sales of cannabis products. Despite operating outside the legal framework established by the OCM, West’s shop reportedly generated nearly $2.4 million in sales during its brief existence.
In June 2023, following numerous complaints from consumers and competitors regarding illegal sales practices, the OCM issued a cease-and-desist order to West. This order mandated that Jaydega 7.0 halt all operations immediately. However, West ignored these directives and continued to operate his business.
Legal Proceedings
The case escalated when Attorney General Letitia James took legal action against West for his blatant disregard of state regulations. The subsequent court ruling culminated in a judgment requiring West to pay $9.5 million $1 million for disgorged illegal profits and $8.4 million in penalties for ongoing violations.
Implications of the Judgment
For George West and Jaydega 7.0
The financial repercussions for West are severe. The $9.5 million penalty not only represents a significant financial burden but also serves as a potential death knell for his business operations. With such a heavy fine looming over him, it is unlikely that Jaydega 7.0 will continue to operate.
For Unlicensed Operators
This ruling sends a clear message to other unlicensed cannabis operators in New York: the state is serious about enforcing its laws and will not tolerate illegal operations that undermine public safety or harm legitimate businesses. The OCM has made it clear that compliance is non-negotiable.
For Licensed Operators
Licensed cannabis businesses may find themselves in a more favorable position following this judgment. As illegal operators are penalized and driven out of business, licensed shops can expect increased market share and consumer trust. Furthermore, this ruling may encourage more consumers to seek out legal products, thereby increasing tax revenue for the state.
Cannabis Regulation in the United States
The Patchwork of State Laws
New York is not alone in grappling with issues related to cannabis regulation; many states across the U.S. have legalized cannabis for medical or recreational use but face challenges with unlicensed operators. The regulatory landscape varies significantly from state to state, creating a patchwork of laws that can be confusing for consumers and businesses alike.
Federal Stance on Cannabis
Despite state-level legalization efforts, cannabis remains classified as a Schedule I substance under federal law, complicating matters further. This federal prohibition creates an environment where unlicensed operators can thrive without fear of federal enforcement while licensed operators face banking challenges and other restrictions.
The Importance of Compliance
As more states move toward legalization, compliance with local regulations becomes increasingly important. States like New York are setting precedents through stringent enforcement actions against unlicensed operators, which could influence how other states approach their own regulatory frameworks.
Public Safety Concerns
Risks Associated with Unregulated Cannabis Sales
Unlicensed cannabis operations pose significant risks to public health and safety. Without regulation, there is no oversight regarding product quality or safety standards, which can lead to dangerous products entering the market. Additionally, unregulated sales often occur without proper age verification or consumer protections.
Consumer Trust and Market Integrity
The presence of unlicensed operators can erode consumer trust in legal markets. When consumers have negative experiences with illegal products whether due to quality issues or unsafe practices they may become disillusioned with legal alternatives as well.
Conclusion
The $9.5 million judgment against George West serves as a critical step toward establishing a safer and more regulated cannabis market in New York. By taking decisive action against unlicensed operators, Attorney General Letitia James is reinforcing the importance of compliance within this evolving industry.
As New York continues to navigate its path toward a fully realized legal cannabis market, this case highlights both the challenges and opportunities that lie ahead. With ongoing enforcement efforts and public awareness campaigns aimed at educating consumers about legal options, New York is poised to create an environment where safe access to cannabis products is not only possible but also prioritized. While this ruling represents a significant setback for George West and other unlicensed operators, it also paves the way for a more robust legal framework that benefits consumers, licensed businesses, and public safety alike. As states across the nation watch closely, New York’s actions may serve as a model for effective cannabis regulation moving forward.
NEW YORK BLACK MARKET PROBLEMS, READ ON…
NEW YORK TRIES TO SHUT DOWN ILLEGAL MARKETS WITH $16 MILLION!
You may like
-
Trudeau’s departure is a turning point for Canada’s cannabis industry
-
EWeb Page / SEC Docs – SEC Charges Acreage Holdings, Inc. For Accounting Violations
-
Try This Marijuana Infused Cassava Cake
-
Joe Rogan Continues To Champion Cannabis
-
Colorado Could Become a Global Hub for Marijuana Genetics
-
How Much Stronger Is THCP Than THC?
Cannabis News
Colorado Could Become a Global Hub for Marijuana Genetics
Published
23 hours agoon
January 23, 2025By
admin
Ability to source marijuana genetic material from outside Colorado
Senate Bill 23-271, which went into effect in early 2024, aims to enhance Colorado’s marijuana industry. A key provision allows licensed marijuana cultivators to source “genetic material” from approved entities in other jurisdictions. Genetic material is defined as material used to propagate cannabis plants, including:
- Immature plants and small plant fragments with ≤0.3% D9 THC on a dry weight basis;
- Cannabis seeds, which grow into marijuana; and
- Tissue cultures.
This law significantly expands sourcing options for Colorado cultivators, including opportunities, both domestic and international. Colorado cultivators can now bring in popular OG strains from around the world.
The anticipated marketing frenzy, however, hasn’t fully materialized. The answer lies in the complexity of transporting genetics across state and international lines.
That’s where we come in. With years of experience advising clients on compliant cross-border transportation, we understand the nuances in the law. Below is a high-level overview of the challenges involved. If you or your clients are ready to make an impact in Colorado’s market, please reach out to me or my team— we’d be happy to assist.
Marijuana genetics: are they hemp or marijuana?
This question – the Schrödinger’s Cat of the cannabis industry – is both simple and complex. In short, under federal law, marijuana genetics appear to be hemp. However, they are neither strictly hemp nor marijuana until a state makes that determination. In fact, in some states they may be both marijuana and hemp.
- “Marihuana” (referred to in this blog post as “marijuana”) is defined in the Controlled Substances Act (“CSA”), as “all parts of the plant Cannabis sativa L., whether growing or not; the seeds thereof; the resin extracted from any part of such plant; and every compound, manufacture, salt, derivative, mixture, or preparation of such plant, its seeds or resin.”
- Marijuana does not include “hemp” as defined in the Agricultural Improvement Act of 2018 (the “2018 Farm Bill”).
- Hemp is defined as the plant Cannabis sativa L. and any part of that plant, including the seeds thereof and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers, whether growing or not, with a delta-9 THC concentration of not more than 0.3 percent on a dry weight basis.
In January 2022, the DEA issued a letter stating that cannabis seeds and other genetic material with ≤0.3% D9 THC meet the definition of hemp and aren’t controlled substances. Importantly, the DEA further clarified in a December 2022 letter that if the cannabis seed germinates into material exceeding 0.3% THC, then “that material” falls within CSA control. DEA’s use of “that material” rather than specifying the seed used to grow “that material” further supports that DEA, at least for now, does not view marijuana genetics (testing at ≤0.3% THC on a dry weight basis) as marijuana.
While these DEA letters aren’t legally binding, they suggest that marijuana genetics, when testing at ≤0.3% D9 THC, are considered hemp under federal law.
State complexities with marijuana and hemp genetics
Since marijuana genetics are currently treated as hemp under federal law, they can move across U.S. state and international lines. However, the 2018 Farm Bill allows states to impose stricter laws.
Some states, like neighboring Arizona, define marijuana genetics as material that will only grow into hemp. Others, like Arkansas, do not expressly exempt “hemp” form the definition of “marijuana,” creating a situation where the genetics are both hemp and marijuana. And States like Mississippi and Minnesota prohibit the sale of cannabis sativa seeds all together.
Understanding both federal and state laws is critical to ensuring a compliant transfer into Colorado. If the exporting state defines the genetics as hemp and permits exports, cultivators can likely import them into Colorado. If the exporting state does not define marijuana genetics as hemp, then selling or transporting marijuana genetics could lead to criminal violations under a state’s marijuana laws.
International considerations
An international import of marijuana genetics must comply with both state, federal, and international laws. As long as the export meets USDA and Customs requirements, federal law typically won’t pose an issue. However, it’s essential to consider the laws of the exporting country, and importing US state, ensuring that the genetics are classified as hemp by both governments. Otherwise, the transport may not only violate a US state’s laws, but also international law.
Conclusion
Licensed Colorado cultivators seeking unique marijuana strains from outside the state—whether from California, Oregon, or countries like Colombia and Jamaica—must navigate both federal and state laws. Harris Sliwoski has extensive experience helping operators transfer cannabis genetics. With our new Denver office, we are ready to assist Colorado cultivators with global genetics imports. A “Tour de Cannabis” anyone?
As cannabis research continues to evolve, scientists have discovered new cannabinoids that change the way we think about the plant’s effects. One of the most exciting discoveries is THCP (Tetrahydrocannabiphorol), a cannabinoid that has been found to be significantly stronger than THC (Tetrahydrocannabinol). For cannabis enthusiasts and researchers alike, this raises questions about just how potent THCP is compared to its more well-known counterpart, THC.
In this blog post, we’ll explore what makes THCP different from THC, how much stronger it is, and what this means for cannabis consumers.
What Is THCP?
THCP, or tetrahydrocannabiphorol, is a recently discovered cannabinoid that shares a similar chemical structure to THC, the most famous psychoactive compound in cannabis. However, the critical difference lies in its molecular structure, which is what makes it so much more potent.
THCP was discovered by Italian researchers in 2019 while studying a particular strain of cannabis. What makes it stand out is the length of its alkyl chain, a feature that affects how it interacts with the body’s cannabinoid receptors.
THCP vs. THC: The Alkyl Chain
The alkyl chain is the part of the cannabinoid that binds to receptors in the body’s endocannabinoid system. THC has a five-link alkyl chain, which allows it to bind effectively to CB1 receptors in the brain, creating the psychoactive “high” that cannabis is known for.
THCP, on the other hand, has a seven-link alkyl chain, which makes it bind more strongly to the CB1 receptors. This increased binding ability is why THCP is believed to be significantly more potent than THC.
How Much Stronger Is THCP Compared to THC?
Research suggests that THCP is up to 33 times more active at CB1 receptors than THC. However, this doesn’t necessarily mean that THCP is 33 times stronger in its effects on the human body. In practice, THCP is estimated to be about 5 to 10 times stronger than THC, depending on factors like dosage, tolerance, and individual body chemistry.
This means that a small dose of THCP could potentially have the same psychoactive effects as a much larger dose of THC. For example, if you’re used to consuming a 10mg THC edible, consuming just 1-2mg of THCP might produce a similar high.
Potency in Psychoactive Effects
According to Burning Daily, the exact experience of THCP’s strength will depend on how it’s consumed. Smoking or vaping THCP-rich cannabis may feel more intense than smoking THC-heavy strains. Because THCP binds more effectively to CB1 receptors, the psychoactive effects may be stronger and last longer, even at lower doses.
In terms of psychoactive effects, users have reported that THCP delivers a more intense and prolonged high than THC. This means that cannabis products containing THCP could be much more potent and should be approached with caution, especially by beginners or those with low tolerance.
How Does THCP Affect the Body?
THCP interacts with the body similarly to THC by engaging with the endocannabinoid system (ECS). The ECS plays a crucial role in regulating various functions, including mood, pain, appetite, and sleep. THC and THCP both bind to CB1 receptors in the brain, which is what causes the well-known psychoactive effects.
However, since THCP binds more strongly to these receptors, the effects are amplified. This could mean stronger feelings of euphoria, relaxation, or altered perception. It could also mean that the therapeutic benefits associated with THC, such as pain relief or stress reduction, are enhanced with THCP.
Potential Benefits of THCP
Because THCP binds more strongly to CB1 receptors, it may offer amplified versions of THC’s benefits. Early research suggests that THCP may be useful for:
- Pain Relief: Given its potency, THCP could provide more powerful pain relief than THC, making it potentially useful for people dealing with chronic pain or severe conditions like fibromyalgia.
- Anti-Inflammatory Effects: THCP may have stronger anti-inflammatory effects, which could make it helpful for conditions like arthritis or inflammatory bowel disease.
- Sleep Aid: Since THC is often used to help with sleep disorders, THCP’s more potent effects could make it a powerful sleep aid for those dealing with insomnia or disrupted sleep patterns.
However, more research is needed to fully understand the range of potential therapeutic benefits that THCP offers.
Are There Any Risks?
Like THC, THCP could have side effects, especially at higher doses. These may include:
- Anxiety or Paranoia: Some people experience increased anxiety or paranoia with high doses of THC, and given THCP’s strength, this effect could be even more pronounced.
- Dry Mouth and Eyes: As with other cannabinoids, THCP may cause dry mouth or red, irritated eyes.
- Increased Heart Rate: THC can cause an elevated heart rate, and THCP might have similar effects, especially in larger doses.
Because of its potency, it’s essential to start with very low doses of THCP to gauge how your body reacts. Those new to cannabis or with a low tolerance should be particularly cautious.
How Does THCP Compare to Other Cannabinoids?
THCP is not the only newly discovered cannabinoid with potent effects. It’s helpful to compare it to other cannabinoids like THC, CBD, and HHC (hexahydrocannabinol) to understand its unique place in the cannabis world.
THCP vs. THC
As mentioned earlier, THCP is much stronger than THC, primarily due to its ability to bind more effectively to CB1 receptors. While THC offers psychoactive effects and various medicinal benefits, THCP amplifies those effects, making it a more potent alternative.
THCP vs. CBD
Unlike THC and THCP, CBD (cannabidiol) is non-psychoactive, meaning it doesn’t get you high. CBD is often used for its potential therapeutic effects, such as reducing anxiety, relieving pain, or helping with sleep, without the intoxication associated with THC. THCP, on the other hand, delivers a much stronger psychoactive experience and should not be confused with CBD.
THCP vs. HHC
HHC (hexahydrocannabinol) is another cannabinoid that’s gaining attention. While HHC offers a more mild high compared to THC, THCP is significantly more potent than both HHC and THC. HHC might be suitable for users looking for a less intense experience, while THCP is better for those seeking a much stronger high.
Is THCP Safe?
Since THCP is still a relatively new discovery, there is limited research on its long-term safety. However, based on its similarity to THC, it’s likely that THCP has a similar safety profile when used in moderation. As with any potent cannabinoid, the key to safe consumption is starting with low doses and increasing gradually.
Because THCP is so much stronger than THC, consuming too much can lead to overconsumption and unpleasant side effects like extreme intoxication, dizziness, or confusion. To avoid these risks, users should always start with a minimal amount of THCP and monitor their reaction.
Conclusion
THCP is an exciting new cannabinoid that has taken the cannabis world by storm due to its incredible potency. With a binding ability up to 33 times stronger than THC, THCP is estimated to be about 5 to 10 times more potent in its psychoactive effects. This means that even small amounts of THCP can deliver a strong, lasting high.
While its potency may offer enhanced therapeutic benefits for pain relief, sleep disorders, and inflammation, it’s crucial to approach THCP with caution. As a new and highly potent compound, it’s best suited for experienced cannabis users who are familiar with THC’s effects and want to explore something stronger.
If you’re new to cannabis or have a low tolerance, starting with small doses of THCP is the best way to ensure a safe and enjoyable experience.
FAQs
- How much stronger is THCP than THC?
THCP is believed to be about 5 to 10 times stronger than THC in terms of psychoactive effects. - Does THCP get you high?
Yes, THCP binds to CB1 receptors in the brain much more effectively than THC, producing a stronger and longer-lasting high. - Is THCP safe to use?
THCP is likely to have a similar safety profile to THC, but due to its potency, it should be used with caution, especially by beginners. - Can THCP help with pain relief?
Early research suggests that THCP could offer stronger pain relief than THC due to its increased potency. - What are the side effects of THCP?
Potential side effects include anxiety, paranoia, dry mouth, and increased heart rate, especially at higher doses.
Cannabis News
America’s Constitutional Conundrum: Guns and Ganja
Published
3 days agoon
January 21, 2025By
admin
Of Guns and Ganja: America’s Constitutional Conundrum
If there’s one thing America is famous for, it’s guns – and lots of ’em! In the land of the free and home of the brave, firearms aren’t just a right, they’re practically a national pastime. With over 400 million firearms floating around a nation of 330 million people, it’s safe to say that guns are as American as apple pie and baseball.
But you know what else Americans love? Drugs. The US remains the world’s largest drug market, with an particularly passionate affair with cannabis. Mary Jane has come a long way since the “Just Say No” propaganda of the D.A.R.E. days. Now, millions of Americans legally light up in their home states, transforming from “criminals” to “consumers” faster than you can say “tax revenue.”
Here’s where things get sticky though. Despite the Biden administration’s vague promises of reform, cannabis remains stubbornly classified as a Schedule I substance at the federal level. This creates a peculiar predicament for freedom-loving Americans who appreciate both their Second Amendment rights and their evening toke.
You see, there’s this obscure interpretation of federal law that says if you consume cannabis – even legally in your state – you’re technically not allowed to own firearms. Let that sink in for a moment: in a country with more guns than people, where cannabis is legally sold in most states, you’re forced to choose between your constitutional right to bear arms and your state-sanctioned right to consume a plant.
As you might imagine, telling Americans they can’t have their guns AND their ganja isn’t exactly going over well. It’s a uniquely American saga that pits state rights against federal law, personal freedom against bureaucratic overreach, and common sense against, well… whatever you’d call this situation.
Let’s dive into this bizarre legal battleground where constitutional rights and cannabis collide.
As America’s cannabis landscape evolves, we’re witnessing a fascinating legal tug-of-war between state sovereignty and federal authority. The latest battleground? The constitutional rights of cannabis consumers to bear arms.
In a groundbreaking decision, the U.S. Court of Appeals for the Fifth Circuit recently reaffirmed that banning occasional marijuana users from owning firearms is unconstitutional. The case, known as U.S. v. Daniels, centers around a man who was sentenced to four years in prison after police found trace amounts of cannabis and firearms during a routine traffic stop. Talk about wrong place, wrong time!
The federal government, particularly under the Biden administration, has been performing some impressive mental gymnastics to justify their position. Their argument? Cannabis users with guns “endanger public safety,” “pose a greater risk of suicide,” and are more likely to commit crimes “to fund their drug habit.” They’ve even argued that cannabis consumers are “unlikely to store their weapons properly.” I guess they never met my ex-military uncle who meticulously organizes his gun safe while enjoying his evening edible.
But here’s where it gets really interesting. The Department of Justice claims the restriction is perfectly constitutional because it aligns with the nation’s history of disarming “dangerous” individuals. They’re essentially putting cannabis users in the same category as folks with domestic violence restraining orders. As someone who’s spent considerable time around both cannabis users and domestic abusers (professionally, of course), I can tell you there’s a slight difference in temperament.
The courts, however, aren’t buying it. As the Fifth Circuit pointed out, the government failed to prove that Daniels was “presently or even regularly intoxicated at the time of arrest.” They noted that even if the government had proven frequent intoxication, they offered “no Founding-era law or practice of disarming ordinary citizens ‘even if their intoxication was routine.'”
The ruling doesn’t completely invalidate the federal statute (known as § 922(g)(3)), but it does expose its shaky constitutional foundation. As the court stated, “This is not a windfall for defendants charged under § 922(g)(3),” but rather a recognition that the government’s enforcement approach is fundamentally flawed.
Meanwhile, the National Rifle Association (NRA) – not exactly known for their progressive stance on substances – acknowledges the absurdity of the situation. They point out that “marijuana use is no longer limited to the domain of indigenous religious customs or youth-oriented counterculture and now includes a wide variety of people who use it for medicinal or recreational reasons.” When even the NRA is suggesting your gun control measure might be a bit extreme, you know something’s amiss.
The result of all this legal wrangling? A patchwork of confusion where state-legal cannabis users must choose between their Second Amendment rights and their medicine or recreational preference. It’s a prime example of how federal prohibition creates more problems than it solves, forcing otherwise law-abiding citizens to become unwitting criminals simply for exercising multiple legal rights simultaneously.
Welcome to America, folks, where you can have your guns or your ganja, but apparently not both – at least until the courts finish sorting out this constitutional cannabis conundrum.
Let me be blunt – we’re caught in a classic American political pretzel. The Biden administration dangles the carrot of rescheduling cannabis to Schedule III, making vague promises that sound good on the campaign trail but do little to address the fundamental issues plaguing cannabis consumers, including their right to bear arms.
While some celebrate these baby steps toward reform, I’ve been around this block enough times to know that rescheduling is like putting a Band-Aid on a bullet wound. It might stop some bleeding, but it doesn’t address the underlying trauma. The gun rights issue is just one of many complications that arise from cannabis’s continued inclusion in the Controlled Substances Act (CSA).
Here’s the uncomfortable truth: there’s only one real solution, and it runs straight through the halls of Congress. The same body that created this mess with the CSA in 1971 is the only one with the power to truly fix it. Congress needs to completely remove cannabis from the CSA – not reschedule it, not modify its status, but fully deschedule it.
Think about it. Rescheduling to Schedule III would still leave cannabis in a weird legal limbo. Sure, it might make research easier and give Big Pharma more room to play, but what about the millions of Americans who use cannabis medicinally or recreationally in their state-legal markets? They’d still be federal criminals, still banned from purchasing firearms, still caught in the crossfire between state and federal law.
The only path forward is complete removal from the CSA, coupled with a federal framework that respects state markets while establishing basic national standards. This would resolve the gun rights issue overnight – no more choosing between your Second Amendment rights and your medicine or recreational preference.
Would I love to see Congress completely overhaul the CSA? Absolutely. The entire scheduling system is based on outdated science and political theater rather than actual harm reduction principles. But let’s be realistic – that’s about as likely as finding bipartisan agreement on… well, anything these days.
Instead, we need to focus on what’s achievable: complete cannabis descheduling. This isn’t just about guns and ganja – it’s about fixing a broken system that’s created countless legal paradoxes and unnecessary criminal penalties. It’s about acknowledging that the emperor has no clothes, that cannabis prohibition has failed, and that it’s time to move forward with a sensible federal policy.
Until Congress acts, we’ll continue to see these legal battles play out in courts across the country, watching judges try to reconcile constitutional rights with outdated federal drug laws. It’s a waste of judicial resources, taxpayer money, and most importantly, it’s a waste of Americans’ time and freedom.
The solution is clear. The only question is: how many more Americans need to get caught in this legal crossfire before Congress finally does its job?
Inspiration:
https://www.marijuanamoment.net/federal-court-reaffirms-that-ban-
on-gun-ownership-for-people-who-occasionally-use-marijuana-is-unconstitutional/
https://www.marijuanamoment.net/nra-says-federal-ban-on-
marijuana-amid-state-level-legalization-has-created-confusing-legal-landscape-for-gun-owners/
CANNABIS AND GUN RIGHTS, READ ON…
Trudeau’s departure is a turning point for Canada’s cannabis industry
EWeb Page / SEC Docs – SEC Charges Acreage Holdings, Inc. For Accounting Violations
Try This Marijuana Infused Cassava Cake
Joe Rogan Continues To Champion Cannabis
Colorado Could Become a Global Hub for Marijuana Genetics
How Much Stronger Is THCP Than THC?
Leafly Buzz: 12 hottest weed strains to smoke in 2025
Can Medical Cannabis Help Support Immune Health?
TikTok’s Double Standard on Marijuana And Alcohol
President Trump will decide marijuana rescheduling, federal reform
Distressed Cannabis Business Takeaways – Canna Law Blog™
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
What you Need to Know
Drug Testing for Marijuana – The Joint Blog
NCIA Write About Their Equity Scholarship Program
It has been a wild news week – here’s how CBD and weed can help you relax
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
A new April 20 cannabis contest includes a $40,000 purse
Your Go-To Source for Cannabis Logos and Designs
UArizona launches online cannabis compliance online course
Trending
-
Cannabis News2 years ago
Distressed Cannabis Business Takeaways – Canna Law Blog™
-
One-Hit Wonders2 years ago
United States: Alex Malyshev And Melinda Fellner Discuss The Intersection Of Tax And Cannabis In New Video Series – Part VI: Licensing (Video)
-
Cannabis 1012 years ago
What you Need to Know
-
drug testing1 year ago
Drug Testing for Marijuana – The Joint Blog
-
Education2 years ago
NCIA Write About Their Equity Scholarship Program
-
Cannabis2 years ago
It has been a wild news week – here’s how CBD and weed can help you relax
-
Marijuana Business Daily2 years ago
Cannabis, alcohol firm SNDL loses CA$372.4 million in 2022
-
California2 years ago
A new April 20 cannabis contest includes a $40,000 purse